AAAAAA

   
Results: 1-19 |
Results: 19
Myasthenia gravis: diagnostic and management dilemmas
Authors: Palace, J Vincent, A Beeson, D
Citation: J. Palace et al., Myasthenia gravis: diagnostic and management dilemmas, CURR OP NEU, 14(5), 2001, pp. 583-589
Myasthenia gravis
Authors: Vincent, A Palace, J Hilton-Jones, D
Citation: A. Vincent et al., Myasthenia gravis, LANCET, 357(9274), 2001, pp. 2122-2128
PRISMS-4: Long-term efficacy of interferon-beta-1a in relapsing MS
Authors: Francis, G Hughes, R King, J Mitchell, P Joubert, J McLeod, J Parker, G Pollard, J Sindic, CJM Duprez, T Medaer, R Broeckx, J Vanroose, E Carton, H Wilms, G Rice, G Ebers, G Lee, DH Freedman, M Nelson, R Rabinovitch, H Christie, S Avruch, L Oger, J Paty, DW Li, D Wikstrom, J Salonen, OLM Panelius, M Eralinna, J Sonninen, P Rieckmann, P Hahn, D Flachenecker, P Hartung, HP Uitdehaag, B Bertelsmann, FW Barkhof, F Hommes, OR Jongen, PJH Van Doorn, PA Tanghe, HLG Sandberg-Wollheim, M Larsson, EM Lonntoft, M Sallerfors, S Kappos, L Lienert, C Radu, EW Chofflon, M Roth, S Castillo, V Schwieger, AF Hughes, RAC Clews, AM Bingham, JB Barnes, D Clifton, AG Stoy, N Bates, D Coulthard, A Blumhardt, LD Evans, SM Jaspan, T Palace, J Newsom-Davis, JM Byrne, JV Quaghebeur, G Li, DKB Paty, DW Zhao, GJ Riddehough, A Rhodes, B
Citation: G. Francis et al., PRISMS-4: Long-term efficacy of interferon-beta-1a in relapsing MS, NEUROLOGY, 56(12), 2001, pp. 1628-1636
Randomized controlled trial of interferon-beta-1a in secondary progressiveMS - Clinical results
Authors: King, J McLeod, J Gonsette, RE Duquette, P Ebers, G Rice, G Francis, G Lapierre, Y Freedman, MS Oger, J Paty, D Sorensen, PS Pelletier, J Hommes, OR Jongen, PJH Sanders, EACM Andersen, O Wollheim-Sandberg, M Chofflon, M Bates, D Barnes, D Blumhardt, LD Hawkins, C Hughes, RAC Palace, J Newsom-Davis, JM Young, CA Ammoury, N Bacchi, M Francis, G Galazka, A Hyde, R Shah, S
Citation: J. King et al., Randomized controlled trial of interferon-beta-1a in secondary progressiveMS - Clinical results, NEUROLOGY, 56(11), 2001, pp. 1496-1504
Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis
Authors: Evangelou, N Konz, D Esiri, MM Smith, S Palace, J Matthews, PM
Citation: N. Evangelou et al., Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis, BRAIN, 124, 2001, pp. 1813-1820
Myasthenia gravis: Basic designs, sample sizes and pitfalls
Authors: Palace, J
Citation: J. Palace, Myasthenia gravis: Basic designs, sample sizes and pitfalls, CLINICAL TRIALS IN NEUROLOGY, 2001, pp. 501-504
The motor cortex shows adaptive functional changes to brain injury from multiple sclerosis
Authors: Lee, M Reddy, H Johansen-Berg, H Pendlebury, S Jenkinson, M Smith, S Palace, J Matthews, PM
Citation: M. Lee et al., The motor cortex shows adaptive functional changes to brain injury from multiple sclerosis, ANN NEUROL, 47(5), 2000, pp. 606-613
Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis
Authors: Evangelou, N Esiri, MM Smith, S Palace, J Matthews, PM
Citation: N. Evangelou et al., Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis, ANN NEUROL, 47(3), 2000, pp. 391-395
Epilepsy: an autoimmune disease?
Authors: Palace, J Lang, B
Citation: J. Palace et B. Lang, Epilepsy: an autoimmune disease?, J NE NE PSY, 69(6), 2000, pp. 711-714
Regional axonal loss in the corpus callosum correlates with cerebral whitematter lesion volume and distribution in multiple sclerosis
Authors: Evangelou, N Konz, D Esiri, MM Smith, S Palace, J Matthews, PM
Citation: N. Evangelou et al., Regional axonal loss in the corpus callosum correlates with cerebral whitematter lesion volume and distribution in multiple sclerosis, BRAIN, 123, 2000, pp. 1845-1849
Axonal injury or loss in the internal capsule and motor impairment in multiple sclerosis
Authors: Lee, MA Blamire, AM Pendlebury, S Ho, KH Mills, KR Styles, P Palace, J Matthews, PM
Citation: Ma. Lee et al., Axonal injury or loss in the internal capsule and motor impairment in multiple sclerosis, ARCH NEUROL, 57(1), 2000, pp. 65-70
Changes in motor evoked potentials to short-interval paired transcranial magnetic stimuli in multiple sclerosis
Authors: Ho, KH Lee, M Nithi, K Palace, J Mills, K
Citation: Kh. Ho et al., Changes in motor evoked potentials to short-interval paired transcranial magnetic stimuli in multiple sclerosis, CLIN NEU, 110(4), 1999, pp. 712-719
The UK Multiple Sclerosis database
Authors: Palace, J Boggild, M
Citation: J. Palace et M. Boggild, The UK Multiple Sclerosis database, MULT SCLER, 5(4), 1999, pp. 297-298
Pathogenic autoantibodies to neuronal proteins in neurological disorders
Authors: Vincent, A Lily, O Palace, J
Citation: A. Vincent et al., Pathogenic autoantibodies to neuronal proteins in neurological disorders, J NEUROIMM, 100(1-2), 1999, pp. 169-180
The effect of anti-alpha 4 integrin antibody on brain lesion activity in MS
Authors: Tubridy, N Behan, PO Capildeo, R Chaudhuri, A Forbes, R Hawkins, CP Hughes, RAC Palace, J Sharrack, B Swingler, R Young, C Moseley, IF MacManus, DG Donoghue, S Miller, DH
Citation: N. Tubridy et al., The effect of anti-alpha 4 integrin antibody on brain lesion activity in MS, NEUROLOGY, 53(3), 1999, pp. 466-472
Association of the APOE epsilon 4 allele with disease activity in multiplesclerosis
Authors: Evangelou, N Jackson, M Beeson, D Palace, J
Citation: N. Evangelou et al., Association of the APOE epsilon 4 allele with disease activity in multiplesclerosis, J NE NE PSY, 67(2), 1999, pp. 203-205
Spatial mapping of T-2 and gadolinium-enhancing T-1 lesion volumes in multiple sclerosis: evidence for distinct mechanisms of lesion genesis?
Authors: Lee, MA Smith, S Palace, J Narayanan, S Silver, N Minicucci, L Filippi, M Miller, DH Arnold, DL Matthews, PM
Citation: Ma. Lee et al., Spatial mapping of T-2 and gadolinium-enhancing T-1 lesion volumes in multiple sclerosis: evidence for distinct mechanisms of lesion genesis?, BRAIN, 122, 1999, pp. 1261-1270
Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis - A longitudinal clinical and MRI study
Authors: Lee, MA Palace, J Stabler, G Ford, J Gearing, A Miller, K
Citation: Ma. Lee et al., Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis - A longitudinal clinical and MRI study, BRAIN, 122, 1999, pp. 191-197
Defining multiple sclerosis disease activity using MRI T-2-weighted difference imaging
Authors: Lee, MA Smith, S Palace, J Matthews, PM
Citation: Ma. Lee et al., Defining multiple sclerosis disease activity using MRI T-2-weighted difference imaging, BRAIN, 121, 1998, pp. 2095-2102
Risultati: 1-19 |